Evaluation of human chorionic gonadotropin and alpha fetoprotein in benign and malignant testicular disorders

M. R. Moore, P. R. Garrett, K. N. Walton, T. A. Waldmann, R. K. McIntire, C. L. Vogel

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

The marker proteins alpha fetoprotein and human chorionic gonadotropin are useful adjuncts to clinical evaluation of patients with nonseminomatous testicular germ cell malignant growths during and after therapeutic interventions. Measuring both markers is better than measuring either one alone. An elevated marker assay indicates the presence of active disease. A normal marker assay does not exclude active disease being present. Lastly, these markers are of limited usefulness in the evaluation of undiagnosed testicular masses.

Original languageEnglish (US)
Pages (from-to)167-174
Number of pages8
JournalSurgery Gynecology and Obstetrics
Volume147
Issue number2
StatePublished - Dec 1 1978
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Evaluation of human chorionic gonadotropin and alpha fetoprotein in benign and malignant testicular disorders'. Together they form a unique fingerprint.

  • Cite this

    Moore, M. R., Garrett, P. R., Walton, K. N., Waldmann, T. A., McIntire, R. K., & Vogel, C. L. (1978). Evaluation of human chorionic gonadotropin and alpha fetoprotein in benign and malignant testicular disorders. Surgery Gynecology and Obstetrics, 147(2), 167-174.